Read by QxMD icon Read


L N Hannivoort, H E M Vereecke, J H Proost, B E K Heyse, D J Eleveld, T W Bouillon, M M R F Struys, M Luginbühl
BACKGROUND: The probability to tolerate laryngoscopy (PTOL) and its derivative, the noxious stimulation response index (NSRI), have been proposed as measures of potency of a propofol-remifentanil drug combination. This study aims at developing a triple drug interaction model to estimate the combined potency of sevoflurane, propofol, and remifentanil in terms of PTOL. We compare the predictive performance of PTOL and the NSRI with various anaesthetic depth monitors. METHODS: Data from three previous studies (n=120) were pooled and reanalysed...
May 2016: British Journal of Anaesthesia
Denise P Veelo, Suzanne S Gisbertz, Rebekka A Hannivoort, Susan van Dieren, Bart F Geerts, Mark I van Berge Henegouwen, Markus W Hollmann
BACKGROUND: Deep muscle relaxation has been shown to facilitate operating conditions during laparoscopic surgery. Minimally invasive esophageal surgery is a high-risk procedure in which the use of deep neuromuscular block (NMB) may improve conditions in the thoracic phase as well. Neuromuscular antagonists can be given on demand or by continuous infusion (deep NMB). However, the positioning of the patient often hampers train-of-four (TOF) monitoring. A continuous infusion thus may result in a deep NMB at the end of surgery...
2015: Trials
Laura N Hannivoort, Douglas J Eleveld, Johannes H Proost, Koen M E M Reyntjens, Anthony R Absalom, Hugo E M Vereecke, Michel M R F Struys
BACKGROUND: Several pharmacokinetic models are available for dexmedetomidine, but these have been shown to underestimate plasma concentrations. Most were developed with data from patients during the postoperative phase and/or in intensive care, making them susceptible to errors due to drug interactions. The aim of this study is to improve on existing models using data from healthy volunteers. METHODS: After local ethics committee approval, the authors recruited 18 volunteers, who received a dexmedetomidine target-controlled infusion with increasing target concentrations: 1, 2, 3, 4, 6, and 8 ng/ml, repeated in two sessions, at least 1 week apart...
August 2015: Anesthesiology
Jaap Jan Vos, Marieke Poterman, Laura N Hannivoort, Victor W Renardel De Lavalette, Michel Mrf Struys, Thomas Wl Scheeren, Alain F Kalmar
BACKGROUND: In particular surgical conditions, a balanced anesthesia with a high-antinociceptive contribution is required. This may induce cardiovascular impairment and thus compromise tissue oxygenation. In this prospective observational study, we investigated the hemodynamic stability and tissue oxygen saturation (StO2) in 40 patients with a high-antinociceptive general anesthesia, goal-directed fluid therapy, and norepinephrine. In addition, optimal surgical conditions and safe and fast emergence are pivotal parts of anesthetic management...
2014: Perioperative Medicine
Bjorn Heyse, Johannes H Proost, Laura N Hannivoort, Douglas J Eleveld, Martin Luginbühl, Michel M R F Struys, Hugo E M Vereecke
BACKGROUND: The authors studied the interaction between sevoflurane and remifentanil on bispectral index (BIS), state entropy (SE), response entropy (RE), Composite Variability Index, and Surgical Pleth Index, by using a response surface methodology. The authors also studied the influence of stimulation on this interaction. METHODS: Forty patients received combined concentrations of remifentanil (0 to 12 ng/ml) and sevoflurane (0.5 to 3.5 vol%) according to a crisscross design (160 concentration pairs)...
June 2014: Anesthesiology
Sandra Dunning, Atta Ur Rehman, Marjolein H Tiebosch, Rebekka A Hannivoort, Floris W Haijer, Jannes Woudenberg, Fiona A J van den Heuvel, Manon Buist-Homan, Klaas Nico Faber, Han Moshage
BACKGROUND: In chronic liver disease, hepatic stellate cells (HSCs) are activated, highly proliferative and produce excessive amounts of extracellular matrix, leading to liver fibrosis. Elevated levels of toxic reactive oxygen species (ROS) produced during chronic liver injury have been implicated in this activation process. Therefore, activated hepatic stellate cells need to harbor highly effective anti-oxidants to protect against the toxic effects of ROS. AIM: To investigate the protective mechanisms of activated HSCs against ROS-induced toxicity...
December 2013: Biochimica et Biophysica Acta
Lars P Bechmann, Diana Vetter, Junichi Ishida, Rebekka A Hannivoort, Ursula E Lang, Peri Kocabayoglu, M Isabel Fiel, Ursula Muñoz, Gillian L Patman, Fengxia Ge, Shoshana Yakar, Xiaosong Li, Loranne Agius, Young-Min Lee, Weijia Zhang, Kei Yiu Hui, Despina Televantou, Gary J Schwartz, Derek LeRoith, Paul D Berk, Ryozo Nagai, Toru Suzuki, Helen L Reeves, Scott L Friedman
BACKGROUND & AIMS: Dysregulated glucose homeostasis and lipid accumulation characterize non-alcoholic fatty liver disease (NAFLD), but underlying mechanisms are obscure. We report here that Krüppel-like factor 6 (KLF6), a ubiquitous transcription factor that promotes adipocyte differentiation, also provokes the metabolic abnormalities of NAFLD by post-transcriptionally activating PPARα-signaling. METHODS: Mice with either hepatocyte-specific depletion of KLF6 ('ΔHepKlf6') or global KLF6 heterozygosity (Klf6+/-) were fed a high fat diet (HFD) or chow for 8 or 16 weeks...
May 2013: Journal of Hepatology
Lars P Bechmann, Peri Kocabayoglu, Jan-Peter Sowa, Svenja Sydor, Jan Best, Martin Schlattjan, Anja Beilfuss, Johannes Schmitt, Rebekka A Hannivoort, Alpaslan Kilicarslan, Christian Rust, Frieder Berr, Oliver Tschopp, Guido Gerken, Scott L Friedman, Andreas Geier, Ali Canbay
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in industrialized countries and may proceed to steatohepatitis (NASH). Apoptosis and free fatty acid (FFA)-induced lipotoxicity are important features of NASH pathogenesis. We have shown a hepatoprotective effect of adiponectin in steatotic livers of hepatitis C virus (HCV) patients and recent data links bile acid (BA) metabolism to the pathogenesis of NAFLD. The aim of this study was to identify potential interactions between BA and FFA metabolism in NAFLD...
April 2013: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
U E Lang, P Kocabayoglu, G Z Cheng, Z Ghiassi-Nejad, U Muñoz, D Vetter, D A Eckstein, R A Hannivoort, M J Walsh, S L Friedman
KLF6, a ubiquitously expressed Krüppel-like transcription factor, is frequently inactivated in human cancer and has significant roles in cellular proliferation, apoptosis, differentiation and development. A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21. Several cancer-derived KLF6 mutants lead to the loss of p21-mediated growth suppression through an unknown mechanism. Because several colorectal cancer and hepatocellular carcinoma-derived KLF6 mutations affect a glycogen synthase kinase 3β (GSK3β) phosphorylation consensus site, we investigated the role of GSK3β in the regulation of KLF6 function...
September 19, 2013: Oncogene
Úrsula Muñoz, Juan E Puche, Rebekka Hannivoort, Ursula E Lang, Michal Cohen-Naftaly, Scott L Friedman
Alternative splicing of the Krüppel-like factor 6 (KLF6) tumor suppressor into an antagonistic splice variant 1 (SV1) is a pathogenic event in several cancers including hepatocellular carcinoma (HCC) because elevated SV1 is associated with increased tumor metastasis and mortality. Ras activation is one factor that can enhance KLF6 splicing in cancer cells, however pathways driving KLF6 splicing are unknown. Splice site selection is regulated by splice factors that include serine/arginine-rich (SR) proteins such as SRSF1 (ASF-SF2), which in turn is controlled by phosphoinositide 3-kinase (PI3K)/Akt and the mitogen-activated protein kinase (MAPK) signaling pathway...
September 2012: Molecular Cancer Research: MCR
Diana Vetter, Michal Cohen-Naftaly, Augusto Villanueva, Youngmin A Lee, Peri Kocabayoglu, Rebekka Hannivoort, Goutham Narla, Josep M Llovet, Swan N Thung, Scott L Friedman
UNLABELLED: KLF6-SV1 (SV1), the major splice variant of KLF6, antagonizes the KLF6 tumor suppressor by an unknown mechanism. Decreased KLF6 expression in human hepatocellular carcinoma (HCC) correlates with increased mortality, but the contribution of increased SV1 is unknown. We sought to define the impact of SV1 on human outcomes and experimental murine hepatocarcinogenesis and to elucidate its mechanism of action. In hepatitis C virus (HCV)-related HCC, an increased ratio of SV1/KLF6 within the tumor was associated with features of more advanced disease...
October 2012: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
Rebekka A Hannivoort, Virginia Hernandez-Gea, Scott L Friedman
Genomics and proteomics have become increasingly important in biomedical science in the past decade, as they provide an opportunity for hypothesis-free experiments that can yield major insights not previously foreseen when scientific and clinical questions are based only on hypothesis-driven approaches. Use of these tools, therefore, opens new avenues for uncovering physiological and pathological pathways. Liver fibrosis is a complex disease provoked by a range of chronic injuries to the liver, among which are viral hepatitis, (non-) alcoholic steatohepatitis and autoimmune disorders...
2012: Fibrogenesis & Tissue Repair
Lars P Bechmann, Rebekka A Hannivoort, Guido Gerken, Gökhan S Hotamisligil, Michael Trauner, Ali Canbay
It is widely known that the liver is a central organ in lipogenesis, gluconeogenesis and cholesterol metabolism. However, over the last decades, a variety of pathological conditions highlighted the importance of metabolic functions within the diseased liver. As observed in Western societies, an increase in the prevalence of obesity and the metabolic syndrome promotes pathophysiological changes that cause non-alcoholic fatty liver disease (NAFLD). NAFLD increases the susceptibility of the liver to acute liver injury and may lead to cirrhosis and hepatocellular cancer...
April 2012: Journal of Hepatology
Lars P Bechmann, Amalia Gastaldelli, Diana Vetter, Gillian L Patman, Laura Pascoe, Rebekka A Hannivoort, Ursula E Lee, Isabel Fiel, Ursula Muñoz, Demetrio Ciociaro, Young-Min Lee, Emma Buzzigoli, Luca Miele, Kei Y Hui, Elisabetta Bugianesi, Alastair D Burt, Christopher P Day, Andrea Mari, Loranne Agius, Mark Walker, Scott L Friedman, Helen L Reeves
UNLABELLED: The polymorphism, KLF6-IVS1-27A, in the Krüppel-like factor 6 (KLF6) transcription factor gene enhances its splicing into antagonistic isoforms and is associated with delayed histological progression of nonalcoholic fatty liver disease (NAFLD). To explore a potential role for KLF6 in the development of insulin resistance, central to NAFLD pathogenesis, we genotyped KLF6-IVS1-27 in healthy subjects and assayed fasting plasma glucose (FPG) and insulin sensitivities. Furthermore, we quantified messenger RNA (mRNA) expression of KLF6 and glucokinase (GCK), as an important mediator of insulin sensitivity, in human livers and in liver tissues derived from a murine Klf6 knockdown model (DeltaKlf6)...
April 2012: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
Mirko Tarocchi, Rebekka Hannivoort, Yujin Hoshida, Ursula E Lee, Diana Vetter, Goutham Narla, Augusto Villanueva, Moshe Oren, Josep M Llovet, Scott L Friedman
UNLABELLED: Inactivation of KLF6 is common in hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) infection, thereby abrogating its normal antiproliferative activity in liver cells. The aim of the study was to evaluate the impact of KLF6 depletion on human HCC and experimental hepatocarcinogenesis in vivo. In patients with surgically resected HCC, reduced tumor expression of KLF6 was associated with decreased survival. Consistent with its role as a tumor suppressor, KLF6+/- mice developed significantly more tumors in response to the chemical carcinogen diethyl nitrosamine (DEN) than wild-type animals...
August 2011: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
Sandra Dunning, Rebekka A Hannivoort, Jan Freark de Boer, Manon Buist-Homan, Klaas Nico Faber, Han Moshage
BACKGROUND: In chronic liver injury, hepatic stellate cells (HSCs) proliferate and produce excessive amounts of connective tissue causing liver fibrosis and cirrhosis. Oxidative stress has been implicated as a driving force of HSC activation and proliferation, although contradictory results have been described. AIM: To determine the effects of oxidative stress on activated HSC proliferation, survival and signalling pathways. METHODS: Serum-starved culture-activated rat HSCs were exposed to the superoxide anion donor menadione (5-25 micromol/L) or hydrogen peroxide (0...
July 2009: Liver International: Official Journal of the International Association for the Study of the Liver
Rebekka A Hannivoort, Sandra Dunning, Sara Vander Borght, Ben Schroyen, Jannes Woudenberg, Fiona Oakley, Manon Buist-Homan, Fiona A J van den Heuvel, Mariska Geuken, Albert Geerts, Tania Roskams, Klaas Nico Faber, Han Moshage
UNLABELLED: Hepatic stellate cells (HSCs) survive and proliferate in the chronically injured liver. ATP-binding cassette (ABC) transporters play a crucial role in cell viability by transporting toxic metabolites or xenobiotics out of the cell. ABC transporter expression in HSCs and its relevance to cell viability and/or activation have not been reported so far. The aim of this study was to investigate the expression, regulation, and function of multidrug resistance-associated protein (Mrp)-type and multidrug resistance protein (Mdr)-type ABC transporters in activated rat HSCs...
August 2008: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
Laura Conde de la Rosa, Titia E Vrenken, Rebekka A Hannivoort, Manon Buist-Homan, Rick Havinga, Dirk-Jan Slebos, Henk F Kauffman, Klaas Nico Faber, Peter L M Jansen, Han Moshage
Most chronic liver diseases are accompanied by oxidative stress, which may induce apoptosis in hepatocytes and liver injury. Oxidative stress induces heme oxygenase-1 (HO-1) expression. This stress-responsive cytoprotective protein is responsible for heme degradation into carbon monoxide (CO), free iron, and biliverdin. CO is an important intracellular messenger; however, the exact mechanisms responsible for its cytoprotective effect are not yet elucidated. Thus, we investigated whether HO-1 and CO protect primary hepatocytes against oxidative-stress-induced apoptosis...
April 1, 2008: Free Radical Biology & Medicine
Gianluca Svegliati-Baroni, Francesco Ridolfi, Rebekka Hannivoort, Stefania Saccomanno, Manon Homan, Samuele De Minicis, Peter L M Jansen, Cinzia Candelaresi, Antonio Benedetti, Han Moshage
BACKGROUND & AIMS: Hepatic stellate cell (HSC) proliferation is a key event in the development of liver fibrosis. In many liver diseases, HSCs are exposed to inflammatory cytokines, reactive oxygen species, and bile acids. Although inflammatory cytokines and reactive oxygen species are known to promote proliferation of HSCs, nothing is known about the effects of bile acids on HSC proliferation or apoptosis. The aim of this study was to investigate the effects of bile acids on HSC proliferation...
April 2005: Gastroenterology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"